Since the drug is not available in the US and not FDA approved, I believe the intent is to limit exposure at this time. imo we will see much more US coverage once the new facility is complete or once FDA approval is gained.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.